Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
MARX Biotech CoROCO:7731 -3.18%10 FCF Yield % is -6.40 as of Jul. 17, 2026. GuruFocus rates ROCO:7731 with a GF Score™ of 10/100. The stock has 4 warning signs investors should review. Among 686 Healthcare Providers & Services companies, MARX Biotech Co ranks worse than 74.2% on this metric.
FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.
The historical rank and industry rank for MARX Biotech Co's FCF Yield % or its related term are showing as below:
ROCO:7731'
s FCF Yield % Range Over the Past 10 Years
Min: -16.34 Med: -5.51 Max: -0.42
Current: -6.4
During the past 6 years, the highest FCF Yield % of MARX Biotech Co was -0.42%. The lowest was -16.34%. And the median was -5.51%.
ROCO:7731's FCF Yield % is ranked worse than 74.2% of 686
companies
in the Healthcare Providers & Services industry
Industry Median: 1.88
vs ROCO:7731: -6.40
Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
MARX Biotech Co FCF Yield % Related Terms
MARX Biotech Co FCF Yield % Historical Data
* Premium members only.
The historical data trend for MARX Biotech Co's FCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Pharmaceutical Retailers subindustry, MARX Biotech Co's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
MARX Biotech Co FCF Yield % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, MARX Biotech Co's FCF Yield % distribution charts can be found below:
* The bar in red indicates where MARX Biotech Co's FCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MARX Biotech Co (ROCO:7731) has a FCF Yield % of -6.40 as of Jul. 17, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on MARX Biotech Co and its competitors. According to the industry distribution chart, MARX Biotech Co ranks #509 out of 686 companies in the Healthcare Providers & Services industry, placing it in the top 74.2%.
Is MARX Biotech Co's FCF Yield % too high?
MARX Biotech Co's current FCF Yield % is -6.40. Based on the distribution chart, MARX Biotech Co ranks #509 out of 686 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, MARX Biotech Co has a GF Score™ of 10/100, reflecting its overall financial health beyond just this single metric.
How does MARX Biotech Co's FCF Yield % compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, MARX Biotech Co ranks #509 out of 686 companies for FCF Yield %. This places MARX Biotech Co in the lower half of its industry. The industry median FCF Yield % is 1.88. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Healthcare Providers & Services company?
The median FCF Yield % among Healthcare Providers & Services companies is 1.88, based on 686 companies in the industry. Companies in the top quartile (top 25%) have a FCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on MARX Biotech Co and its competitors. For the Healthcare Providers & Services industry, the median FCF Yield % is 1.88 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. MARX Biotech Co's current FCF Yield % is -6.40. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MARX Biotech Co stock overvalued right now?
MARX Biotech Co (ROCO:7731) has a current FCF Yield % of -6.40. The current FCF Yield % is -6.40. MARX Biotech Co's overall GF Score™ is 10/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For MARX Biotech Co (ROCO:7731), the current FCF Yield % is -6.40 as of Jul. 17, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
MARX Biotech Co Ltd is a retail company which has developed an O2O and OMO full-channel layout in the online Internet platform and cosmeceutical retail market, and has successfully established itself in the market and Build trust and operational growth on the channel side. It has has established more than three thousand large and small cosmeceutical pharmacies in Taiwan, including: Dashu Pharmacy, Dingding Pharmacy, Cosmed, Watsons, Spring Pharmacy, New Gaoqiao Pharmacy, Anlier Pharmacies, etc.
10GF Score
Get the complete analysis for ROCO:7731
FCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:7731 has been successfully added to your 
